Olmesartan + HCTZ + Amlodipine Tablet

Olmesartan + HCTZ + Amlodipine Tablet

Categories : Cardiovascular System

Product Packaging : 10 / 30 tablets

Product Composition : 20 mg + 12.5 mg + 5 mg, 40 mg + 12.5 mg + 5 mg

Send Message

Olmesartan + Hydrochlorothiazide 12.5 mg + Amlodipine Tablets are triple-combination antihypertensive formulations developed for patients requiring comprehensive blood pressure management. The combination integrates an angiotensin receptor blocker, a diuretic, and a calcium channel blocker to provide effective and sustained control of hypertension. Genliva Wellness LLP offers high-quality Olmesartan HCTZ Amlodipine Tablets for Global Pharmaceutical Markets.

This advanced cardiovascular formulation is commonly prescribed when dual therapy does not provide adequate blood pressure control. The synergistic action of all three ingredients helps improve vascular relaxation, reduce fluid retention, and support healthy cardiovascular function. As a trusted Olmesartan HCTZ Amlodipine Tablet Exporter from India, we serve pharmaceutical distributors and healthcare organizations worldwide.

Manufactured under stringent quality standards and international pharmaceutical guidelines, the product ensures consistent efficacy and patient safety. Genliva Wellness LLP is a reliable Triple Combination Antihypertensive Tablet Manufacturer in India, offering contract manufacturing and export solutions for global markets.

Olmesartan + HCTZ 12.5 mg + Amlodipine Tablets are formulated for comprehensive blood pressure management.

  • Combination of Olmesartan, Hydrochlorothiazide, and Amlodipine
  • Triple-action antihypertensive therapy
  • Supports effective blood pressure control
  • Helps improve vascular relaxation
  • Reduces fluid retention
  • Suitable for long-term cardiovascular care

Olmesartan + HCTZ 12.5 mg + Amlodipine Tablets are used for the management of hypertension.

  • Essential hypertension
  • Uncontrolled high blood pressure
  • Combination antihypertensive therapy
  • Cardiovascular risk reduction
  • Long-term blood pressure management
  • Supportive cardiovascular treatment

The triple-combination formulation provides enhanced blood pressure control through complementary mechanisms of action.

  • Triple-action antihypertensive effect
  • Helps achieve better blood pressure control
  • Supports cardiovascular protection
  • Improves treatment outcomes in resistant hypertension

whatsapp-app